# Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma

> **NCT00534664** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 40 (actual)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DEVICE:** TheraBionic device

## Key facts

- **NCT ID:** NCT00534664
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534664, "Phase I/II Study of Amplitude-Modulated Electromagnetic Fields in the Treatment of Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00534664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*